Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • The share is getting closer to its long-term support in weekly data, at USD 74.04, which offers good timing for buyers.
  • The close medium term support offers good timing for purchasing the stock.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.56 for the 2017 fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses

No significant weakness

Ratings chart
Subsector Drug Retailers - NEC
1st jan.Capitalisation (M$)Investor Rating
CVS HEALTH-1.61%79 048
WALGREENS BOOTS ALLIANCE-1.79%86 977
EXPRESS SCRIPTS HOLDING CO-10.42%35 589
MCKESSON CORPORATION5.57%31 177
CARDINAL HEALTH INC-10.55%20 702
AMERISOURCEBERGEN CORP.1.33%17 360
JOINTOWN PHARMACEUTICAL GRO..-2.99%5 291
CHINA NATIONAL ACCORD MEDIC..--.--%4 585
MEDIPAL HOLDINGS CORP3.20%4 228
WELCIA HOLDINGS CO LTD21.01%4 069
CHINA NATIONAL MEDICINES CO..5.91%3 811
Autres valeurs du secteur
Company
Operates as an integrated pharmacy health care providerCVS Health Corp. engages in the provision of health care services.It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate.The Pharmacy Services segment offers pharmacy benefit management... 
Sector
Drug Retailers
Calendar
11/07Earnings Release
Financials ($)
Sales 2017 184 098 M
EBIT 2017 10 053 M
Net income 2017 5 304 M
Debt 2017 24 744 M
Yield 2017 2,54%
P/E ratio 2017 15,44
P/E ratio 2018 13,20
EV / Sales 2017 0,56x
EV / Sales 2018 0,54x
Capitalization 79 048 M
Chart CVS HEALTH
Duration : Period : Day
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Duration : Period : Week
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes